BioAtla Inc.

NASDAQ: BCAB · Real-Time Price · USD
0.48
-0.03 (-5.46%)
At close: Jun 10, 2025, 3:59 PM

BioAtla Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
11M n/a n/a 250K
Cost of Revenue
n/a 1.22M 1.2M 1.33M
Gross Profit
10.07M -103.73M -1.2M -1.08M
Operating Income
-73.94M -129.69M -108.14M -96.44M
Interest Income
3.37M 6.31M 1.65M 350K
Pretax Income
-69.78M -123.46M -106.48M -95.4M
Net Income
-69.78M -123.46M -105.28M -95.41M
Selling & General & Admin
21.85M 25.96M 28.79M 38.42M
Research & Development
63.09M 103.73M 79.35M 58.27M
Other Expenses
n/a -103.73M 10K 1K
Operating Expenses
84.94M 129.69M 108.14M 96.69M
Interest Expense
n/a n/a n/a 3K
Selling & Marketing Expenses
n/a n/a n/a n/a
Cost & Expenses
84.94M 129.69M 108.14M 96.69M
Income Tax Expense
n/a n/a -1.2M 4K
Shares Outstanding (Basic)
48.57M 47.78M 38.93M 34.56M
Shares Outstanding (Diluted)
48.57M 47.78M 38.93M 34.56M
EPS (Basic)
-1.44 -2.58 -2.7 -2.76
EPS (Diluted)
-1.44 -2.58 -2.7 -2.76
EBITDA
-73.94M -122.24M -106.48M -94.07M
EBIT
-73.94M -123.46M -106.48M -95.4M
Depreciation & Amortization
n/a 1.22M 1.2M 1.33M